Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 3:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1969–1992 of 6,925 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Tobacco Use Disorder, Smoking Cessation
Interventions: Web-based curriculum on tobacco dependence treatment, Tobacco Counseling Role Play, Preceptor Training and Teaching Medical Students, Booster Session; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 13
States / cities: Birmingham, Alabama • Stanford, California • Washington D.C., District of Columbia + 10 more

Conditions: Non-small Cell Lung Cancer
Interventions: Selected Vegetable and Herb Mix; Drug
Lead sponsor: Sun Farm Corporation; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: New York, New York

Conditions: Alcohol Use, Unspecified
Interventions: Most hoped for future self, Most feared future self, Control (trip to zoo), Balanced future self; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 17 Years to 19 Years
Enrollment: 468 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chronic Abdominal Pain, Small Intestinal Bacterial Overgrowth
Interventions: Lactulose Breath Test, xifaxan, placebo; Procedure · Drug
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 8 Years to 18 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dehydration, Heat Stress
Interventions: Education and resources provided by community health workers; Other
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: El Centro, California

Conditions: Hemophilia A
Interventions: Recombinant Protein-Free Factor VIII (rAHF-PFM); Drug
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2015
U.S. locations: 10
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Chicago, Illinois + 7 more

Conditions: Smoking
Interventions: Computer-delivered brief intervention (5As), Contingency Management; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Substance Use Disorders
Interventions: Modified Family Talk, Control-like parameter estimation; Other
Lead sponsor: Brown University; Other
Eligibility: 12 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Pawtucket, Rhode Island

Conditions: Depression
Interventions: Parent-Directed Online Single-Session Program, Youth-Directed Online Single-Session Program, Information/Psychoeducation/Referral; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: 11 Years to 16 Years
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Hearing Disability, Anxiety, Mobility Disability
Interventions: Sham Digital Program - General health education and interactive quizzes unrelated to anxiety or CBT., Toivoa-001 - A digital Cognitive Behavioral Therapy program combined with NBHWC-certified coaching.; Device
Lead sponsor: Toivoa Inc; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Dover, Delaware • East Orange, New Jersey • Cleveland, Ohio + 1 more

Conditions: Obesity, Childhood
Interventions: Coaching, Materials; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 8 Years to 12 Years
Enrollment: 501 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Positive Parenting Skills
Interventions: Positive Parenting Seminar Series; Behavioral
Lead sponsor: Texas Tech University; Other
Eligibility: Not listed
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Breast Cancer, Colon Cancer
Interventions: Research-grade accelerometer, National Comprehensive Cancer Network (NCCN) Education Materials, Garmin Vivofit activity tracker, Exercise Consultation Calls, Interview, Physical Activity Index Assessment (Intervention Arm), Physical Activity Index Assessment (Control Arm), Health Surveys; Device · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 50 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Infections, Bacterial
Interventions: 500mg IV GSK1322322/placebo, 1000mg oral GSK1322322/placebo, 1000mg IV GSK1322322/placebo, 1500mg oral GSK1322322/placebo dose, 1500mg IV GSK1322322/placebo, 2000mg IV GSK1322322J/placebo, 3000mg IV GSK1322322J/placebo, 1000mg IV GSK1322322J/placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Sunscreening Agents
Interventions: Sunscreen Sport Spray (BAY987519), Untreated Skin; Drug · Other
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Non-Squamous Non-Small Cell Lung Cancer
Interventions: erlotinib, onartuzumab, placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 15
States / cities: Bakersfield, California • Fullerton, California • Long Beach, California + 11 more

Conditions: Dentin Sensitivity
Interventions: 12027-019, 12027-020, 12027-021; Device
Lead sponsor: Johnson & Johnson Consumer and Personal Products Worldwide; Industry
Eligibility: 18 Years and older
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Inactivity, Physical, Sedentary Behavior
Interventions: COT-Based Intervention; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 25 Years to 80 Years
Enrollment: 386 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Melanoma
Interventions: CP 870,893, Peptides, Oncovir poly IC:LC; Drug · Biological
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Alzheimer Disease
Interventions: 15mg T3D-959, 30 mg T3D-959, 45 mg T3D-959, Placebos; Drug
Lead sponsor: T3D Therapeutics, Inc.; Industry
Eligibility: 50 Years to 90 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cancer of the Breast, Anomaly of Breast
Interventions: Autologous Fat Grafting of the Breast, Control Arm; Procedure · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older · Female only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Clackamas, Oregon

Conditions: Head Lice Infestation
Interventions: Abametapir Lotion 0.74% w/w, Vehicle Lotion; Drug
Lead sponsor: Dr. Reddy's Laboratories Limited; Industry
Eligibility: 6 Months and older
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 7
States / cities: Dinuba, California • Los Angeles, California • West Palm Beach, Florida + 4 more

Conditions: Brain Tumor
Interventions: C-SMART, BE Well; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Cystic Fibrosis
Interventions: High-Flow, 20 LPM (via Optiflow cannula), Low FLow, 5 LPM (via Optiflow cannula); Device
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 10 Years to 50 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

Tobacco Treatment Medical Education in 10 Medical Schools

Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer

Narrative Writing to Promote Healthy Decisions About Alcohol During the Transition Out of High School

Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth?

Implementing an Intervention to Reduce Heat Stress and Chemical Exposures

Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery

Computer-Assisted Intervention for Smoking During Pregnancy

Substance Use Prevention for Youth With Parents in Recovery

Promoting Treatment Access Following Pediatric Primary Care Depression Screening

Reduction of Anxiety Through Dual Treatment: Digital CBT & NBHWC Coaching

FITLINE: Pediatric Practice-based Obesity Intervention to Support Families

Investigating a Brief Virtual Seminar Series for Parents of Teens Ages 13-17

Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects

Human Phototoxicity Test

A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation

Tooth Sensitivity Relief by Two Mouthrinses

The YourMove Study: Optimizing Individualized and Adaptive mHealth Interventions Via Control Systems Engineering Methods

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects

A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

C-SMART vs BE Well for Patients With Brain Tumors

Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis